Trials / Completed
CompletedNCT00348725
Acceptability of a Fixed Combination of Fenofibrate and Metformin
An Open Label, Parallel-Arm, Multicenter Trial Assessing the Acceptability of 4 Dosages of a New Fixed Dose Combination of Fenofibrate and Metformin in Patients With Type 2 Diabetes and Dyslipidemia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 69 (planned)
- Sponsor
- Solvay Pharmaceuticals · Industry
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective was to assess the acceptability of a 4-week treatment of 4 new fixed-dose combinations of fenofibrate and metformin, in patients with type 2 diabetes and dyslipidemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | fenofibrate and metformin fixed combination (drug) |
Timeline
- Start date
- 2005-04-01
- First posted
- 2006-07-06
- Last updated
- 2007-09-03
Locations
25 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00348725. Inclusion in this directory is not an endorsement.